Scavenger receptor CD36 is essential for the cerebrovascular oxidative stress and neurovascular dysfunction induced by amyloid-β

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 12, 2011, Pages 5063-5068

  Park, Laibaik ^a   Wang, Gang ^a   Zhou, Ping ^a   Zhou, Joan ^a   Pitstick, Rose ^b   Previti, Mary Lou ^c   Younkin, Linda ^d   Younkin, Steven G ^d   Van Nostrand, William E ^c   Cho, Sunghee ^e   Anrather, Josef ^a   Carlson, George A ^b   Iadecola, Costantino ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b MCLAUGHLIN RESEARCH INSTITUTE   (United States)

^c STONY BROOK UNIVERSITY   (United States)

^d MAYO CLINIC   (United States)

^e BURKE REHABILITATION HOSPITAL   (United States)

Author keywords

Alzheimer's disease; Functional hyperemia; Nox2; Receptor for advanced glycation end products

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; MEMBRANE PROTEIN; SCAVENGER RECEPTOR; SCAVENGER RECEPTOR CD 36; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN ARTERY; BRAIN BLOOD FLOW; BRAIN BLOOD VESSEL; BRAIN DYSFUNCTION; CEREBROVASCULAR DISEASE; GENE MUTATION; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SOMATOSENSORY CORTEX;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIGENS, CD36; CEREBROVASCULAR CIRCULATION; CEREBROVASCULAR DISORDERS; FEMALE; HUMANS; MALE; MICE; MICE, TRANSGENIC; MUTATION; NADPH OXIDASE; OXIDATIVE STRESS; PEPTIDE FRAGMENTS; PROTEIN BINDING; SOMATOSENSORY CORTEX;

MUS; MUS MUSCULUS;

EID: 79953213351     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1015413108     Document Type: Article

References (36)

1. Iadecola C (2010) The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia. Acta Neuropathol 120:287-296.
2. Querfurth HW, LaFerla FM (2010) Alzheimer's disease. N Engl J Med 362:329-344.
3. Iadecola C (2004) Neurovascular regulation in the normal brain and in Alzheimer's disease. Nat Rev Neurosci 5:347-360.
4. de la Torre JC (2010) Vascular risk factor detection and control may prevent Alzheimer's disease. Ageing Res Rev 9:218-225.
5. Schneider JA, Bennett DA (2010) Where vascular meets neurodegenerative disease. Stroke 41(Suppl):S144-S146.
6. Snowdon DA; Nun Study (2003) Healthy aging and dementia: findings from the Nun Study. Ann Intern Med 139:450-454.
7. Zlokovic BV (2008) The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 57:178-201.
8. Moskowitz MA, Lo EH, Iadecola C (2010) The science of stroke: Mechanisms in search of treatments. Neuron 67:181-198.
9. Cipolla MJ (2010) The Cerebral Circulation (Morgan and Claypool, San Francisco).
10. Silverstein RL, Febbraio M (2009) CD36, a scavenger receptor involved in immunity, metabolism, angiogenesis, and behavior. Sci Signal 2:1-8.
11. Wilkinson B, Koenigsknecht-Talboo J, Grommes C, Lee CY, Landreth G (2006) Fibrillar beta-amyloid-stimulated intracellular signaling cascades require Vav for induction of respiratory burst and phagocytosis in monocytes and microglia. J Biol Chem 281:20842-20850. (Pubitemid 44115425)
12. Coraci IS, et al. (2002) CD36, a class B scavenger receptor, is expressed on microglia in Alzheimer's disease brains and can mediate production of reactive oxygen species in response to beta-amyloid fibrils. Am J Pathol 160:101-112. (Pubitemid 34052271)
13. Bianca VD, Dusi S, Bianchini E, Dal Prà I, Rossi F (1999) beta-amyloid activates the O-2 forming NADPH oxidase in microglia, monocytes, and neutrophils. A possible inflammatory mechanism of neuronal damage in Alzheimer's disease. J Biol Chem 274:15493-15499.
14. Kazama K, et al. (2004) Angiotensin II impairs neurovascular coupling in neocortex through NADPH oxidase-derived radicals. Circ Res 95:1019-1026. (Pubitemid 39532332)
15. Gurol ME, et al. (2006) Plasma beta-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy. Neurology 66:23-29.
16. van Dijk EJ, et al. (2007) Plasma beta amyloid and impaired CO2-induced cerebral vasomotor reactivity. Neurobiol Aging 28:707-712. (Pubitemid 46349355)
17. Deane R, et al. (2003) RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain. Nat Med 9:907-913. (Pubitemid 36889934)
18. Hsiao K, et al. (1996) Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 274:99-102.
19. Verdier Y, Zarándi M, Penke B (2004) Amyloid beta-peptide interactions with neuronal and glial cell plasma membrane: Binding sites and implications for Alzheimer's disease. J Pept Sci 10:229-248. (Pubitemid 38594184)
20. Husemann J, Loike JD, Anankov R, Febbraio M, Silverstein SC (2002) Scavenger receptors in neurobiology and neuropathology: Their role on microglia and other cells of the nervous system. Glia 40:195-205. (Pubitemid 35337377)
21. Bamberger ME, Harris ME, McDonald DR, Husemann J, Landreth GE (2003) A cell surface receptor complex for fibrillar beta-amyloid mediates microglial activation. J Neurosci 23:2665-2674. (Pubitemid 36418601)
22. Niwa K, Carlson GA, Iadecola C (2000) Exogenous A beta1-40 reproduces cerebrovascular alterations resulting from amyloid precursor protein overexpression in mice. J Cereb Blood Flow Metab 20:1659-1668.
23. Graff-Radford NR, et al. (2007) Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease. Arch Neurol 64:354-362. (Pubitemid 46425689)
24. Park L, et al. (2008) Nox2-derived radicals contribute to neurovascular and behavioral dysfunction in mice overexpressing the amyloid precursor protein. Proc Natl Acad Sci USA 105:1347-1352. (Pubitemid 351397056)
25. Cole GM, et al. (2004) NSAID and antioxidant prevention of Alzheimer's disease: Lessons from in vitro and animal models. Ann N Y Acad Sci 1035:68-84. (Pubitemid 40362327)
26. Lim GP, et al. (2001) The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J Neurosci 21:8370-8377. (Pubitemid 33051435)
27. Iadecola C, et al. (1999) SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein. Nat Neurosci 2:157-161. (Pubitemid 30491316)
28. Abe T, et al. (2010) Key role of CD36 in Toll-like receptor 2 signaling in cerebral ischemia. Stroke 41:898-904.
29. Hoebe K, et al. (2005) CD36 is a sensor of diacylglycerides. Nature 433:523-527. (Pubitemid 40204309)
30. Stewart CR, et al. (2010) CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nat Immunol 11:155-161.
31. Triantafilou M, et al. (2006) Membrane sorting of toll-like receptor (TLR)-2/6 and TLR2/1 heterodimers at the cell surface determines heterotypic associations with CD36 and intracellular targeting. J Biol Chem 281:31002-31011. (Pubitemid 44582155)
32. Reed-Geaghan EG, Savage JC, Hise AG, Landreth GE (2009) CD14 and toll-like receptors 2 and 4 are required for fibrillar Abeta-stimulated microglial activation. J Neurosci 29:11982-11992.
33. Febbraio M, et al. (1999) A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism. J Biol Chem 274:19055-19062.
34. Judkins CP, et al. (2010) Direct evidence of a role for Nox2 in superoxide production, reduced nitric oxide bioavailability, and early atherosclerotic plaque formation in ApoE-/- mice. Am J Physiol Heart Circ Physiol 298:H24-H32.
35. Park L, Anrather J, Girouard H, Zhou P, Iadecola C (2007) Nox2-derived reactive oxygen species mediate neurovascular dysregulation in the aging mouse brain. J Cereb Blood Flow Metab 27:1908-1918. (Pubitemid 350129160)
36. Chen Y, et al. (2004) Retroviral delivery of homeobox D3 gene induces cerebral angiogenesis in mice. J Cereb Blood Flow Metab 24:1280-1287. (Pubitemid 39482491)